HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ICAM-3 endows anticancer drug resistance against microtubule-damaging agents via activation of the ICAM-3-AKT/ERK-CREB-2 pathway and blockage of apoptosis.

Abstract
In a previous study, we showed that induction of ICAM-3 endows radioresistance in cervical cancer [1]. To ascertain whether ICAM-3 also promotes anticancer drug resistance, mock control (H1299/pcDNA3) or ICAM-3-expressing stable transfectants (H1299/ICAM-3) of the non-small cell lung cancer (NSCLC) cell line, NCI-H1299, were generated and treated with the microtubule-damaging agents, paclitaxel (TXL) and vincristine (VCS). TXL-/VCS-treated H1299/ICAM-3 cells showed significantly lower levels of apoptosis, activation of caspases-3, 8 or 9, and decrease in anti-apoptotic protein levels, compared to H1299/pcDNA3 cells. Our data clearly indicate that ICAM-3 promotes drug resistance via inhibition of apoptosis. We additionally showed that Akt, ERK, and CREB-2 are located downstream of ICAM-3, and activation of the ICAM-3-Akt/ERK-CREB-2 pathway induces resistance against TXL and VCS. ICAM-3-expressing stable NCI-H460/ICAM-3 transfectant cells and radioresistant SiHa cells endogenously overexpressing ICAM-3 additionally showed drug resistance against TXL and VCS via activation of the ICAM-3-Akt/ERK-CREB-2 pathway. The finding that ICAM-3 endows drug resistance as well as radioresistance supports its potential utility as a major therapeutic target against cancer.
AuthorsKwang-Chul Ahn, Jae Yeon Choi, Jae-Sung Kim, Sang-Gu Hwang, Wun-Jae Kim, Jong Kuk Park, Hong-Duck Um
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 441 Issue 2 Pg. 507-13 (Nov 15 2013) ISSN: 1090-2104 [Electronic] United States
PMID24177012 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • ATF2 protein, human
  • Activating Transcription Factor 2
  • Antigens, CD
  • Antineoplastic Agents
  • Cell Adhesion Molecules
  • ICAM3 protein, human
  • Tubulin Modulators
  • Proto-Oncogene Proteins c-akt
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Activating Transcription Factor 2 (metabolism)
  • Antigens, CD (genetics, physiology)
  • Antineoplastic Agents (pharmacology)
  • Apoptosis
  • Cell Adhesion Molecules (genetics, physiology)
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Humans
  • Metabolic Networks and Pathways
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Tubulin Modulators (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: